Cargando…

A Single Intranasal Dose of Bacterial Therapeutics to Calves Confers Longitudinal Modulation of the Nasopharyngeal Microbiota: a Pilot Study

To address the emergence of antimicrobial-resistant pathogens in livestock, microbiome-based strategies are increasingly being sought to reduce antimicrobial use. Here, we describe the effects of intranasal application of bacterial therapeutics (BTs) on the bovine respiratory microbiota and used str...

Descripción completa

Detalles Bibliográficos
Autores principales: Amat, Samat, Timsit, Edouard, Workentine, Matthew, Schwinghamer, Timothy, van der Meer, Frank, Guo, Yongmei, Alexander, Trevor W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10134831/
https://www.ncbi.nlm.nih.gov/pubmed/36971568
http://dx.doi.org/10.1128/msystems.01016-22
_version_ 1785031838698307584
author Amat, Samat
Timsit, Edouard
Workentine, Matthew
Schwinghamer, Timothy
van der Meer, Frank
Guo, Yongmei
Alexander, Trevor W.
author_facet Amat, Samat
Timsit, Edouard
Workentine, Matthew
Schwinghamer, Timothy
van der Meer, Frank
Guo, Yongmei
Alexander, Trevor W.
author_sort Amat, Samat
collection PubMed
description To address the emergence of antimicrobial-resistant pathogens in livestock, microbiome-based strategies are increasingly being sought to reduce antimicrobial use. Here, we describe the effects of intranasal application of bacterial therapeutics (BTs) on the bovine respiratory microbiota and used structural equation modeling to investigate the causal networks after BT application. Beef cattle received (i) an intranasal cocktail of previously characterized BT strains, (ii) an injection of metaphylactic antimicrobial (tulathromycin), or (iii) intranasal saline. Despite being transient colonizers, inoculated BT strains induced longitudinal modulation of the nasopharyngeal bacterial microbiota while showing no adverse effect on animal health. The BT-mediated changes in bacteria included reduced diversity and richness and strengthened cooperative and competitive interactions. In contrast, tulathromycin increased bacterial diversity and antibiotic resistance and disrupted bacterial interactions. Overall, a single intranasal dose of BTs can modulate the bovine respiratory microbiota, highlighting that microbiome-based strategies have potential in being utilized to mitigate bovine respiratory disease in feedlot cattle. IMPORTANCE Bovine respiratory disease (BRD) remains the most significant health challenge affecting the North American beef cattle industry and results in $3 billion in economic losses yearly. Current BRD control strategies mainly rely on antibiotics, with metaphylaxis commonly employed to mitigate BRD incidence in commercial feedlots. However, the emergence of multidrug-resistant BRD pathogens threatens to reduce the efficacy of antimicrobials. Here, we investigated the potential use of novel bacterial therapeutics (BTs) to modulate the nasopharyngeal microbiota in beef calves, which are commonly administered metaphylactic antibiotics to mitigate BRD when sourced from auction markets. By direct comparison of the BTs with an antibiotic commonly used for BRD metaphylaxis in feedlots, this study conveyed the potential use of the BTs to modulate respiratory microbiome and thereby improve resistance against BRD in feedlot cattle.
format Online
Article
Text
id pubmed-10134831
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher American Society for Microbiology
record_format MEDLINE/PubMed
spelling pubmed-101348312023-04-28 A Single Intranasal Dose of Bacterial Therapeutics to Calves Confers Longitudinal Modulation of the Nasopharyngeal Microbiota: a Pilot Study Amat, Samat Timsit, Edouard Workentine, Matthew Schwinghamer, Timothy van der Meer, Frank Guo, Yongmei Alexander, Trevor W. mSystems Research Article To address the emergence of antimicrobial-resistant pathogens in livestock, microbiome-based strategies are increasingly being sought to reduce antimicrobial use. Here, we describe the effects of intranasal application of bacterial therapeutics (BTs) on the bovine respiratory microbiota and used structural equation modeling to investigate the causal networks after BT application. Beef cattle received (i) an intranasal cocktail of previously characterized BT strains, (ii) an injection of metaphylactic antimicrobial (tulathromycin), or (iii) intranasal saline. Despite being transient colonizers, inoculated BT strains induced longitudinal modulation of the nasopharyngeal bacterial microbiota while showing no adverse effect on animal health. The BT-mediated changes in bacteria included reduced diversity and richness and strengthened cooperative and competitive interactions. In contrast, tulathromycin increased bacterial diversity and antibiotic resistance and disrupted bacterial interactions. Overall, a single intranasal dose of BTs can modulate the bovine respiratory microbiota, highlighting that microbiome-based strategies have potential in being utilized to mitigate bovine respiratory disease in feedlot cattle. IMPORTANCE Bovine respiratory disease (BRD) remains the most significant health challenge affecting the North American beef cattle industry and results in $3 billion in economic losses yearly. Current BRD control strategies mainly rely on antibiotics, with metaphylaxis commonly employed to mitigate BRD incidence in commercial feedlots. However, the emergence of multidrug-resistant BRD pathogens threatens to reduce the efficacy of antimicrobials. Here, we investigated the potential use of novel bacterial therapeutics (BTs) to modulate the nasopharyngeal microbiota in beef calves, which are commonly administered metaphylactic antibiotics to mitigate BRD when sourced from auction markets. By direct comparison of the BTs with an antibiotic commonly used for BRD metaphylaxis in feedlots, this study conveyed the potential use of the BTs to modulate respiratory microbiome and thereby improve resistance against BRD in feedlot cattle. American Society for Microbiology 2023-03-27 /pmc/articles/PMC10134831/ /pubmed/36971568 http://dx.doi.org/10.1128/msystems.01016-22 Text en © Crown copyright 2023. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research Article
Amat, Samat
Timsit, Edouard
Workentine, Matthew
Schwinghamer, Timothy
van der Meer, Frank
Guo, Yongmei
Alexander, Trevor W.
A Single Intranasal Dose of Bacterial Therapeutics to Calves Confers Longitudinal Modulation of the Nasopharyngeal Microbiota: a Pilot Study
title A Single Intranasal Dose of Bacterial Therapeutics to Calves Confers Longitudinal Modulation of the Nasopharyngeal Microbiota: a Pilot Study
title_full A Single Intranasal Dose of Bacterial Therapeutics to Calves Confers Longitudinal Modulation of the Nasopharyngeal Microbiota: a Pilot Study
title_fullStr A Single Intranasal Dose of Bacterial Therapeutics to Calves Confers Longitudinal Modulation of the Nasopharyngeal Microbiota: a Pilot Study
title_full_unstemmed A Single Intranasal Dose of Bacterial Therapeutics to Calves Confers Longitudinal Modulation of the Nasopharyngeal Microbiota: a Pilot Study
title_short A Single Intranasal Dose of Bacterial Therapeutics to Calves Confers Longitudinal Modulation of the Nasopharyngeal Microbiota: a Pilot Study
title_sort single intranasal dose of bacterial therapeutics to calves confers longitudinal modulation of the nasopharyngeal microbiota: a pilot study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10134831/
https://www.ncbi.nlm.nih.gov/pubmed/36971568
http://dx.doi.org/10.1128/msystems.01016-22
work_keys_str_mv AT amatsamat asingleintranasaldoseofbacterialtherapeuticstocalvesconferslongitudinalmodulationofthenasopharyngealmicrobiotaapilotstudy
AT timsitedouard asingleintranasaldoseofbacterialtherapeuticstocalvesconferslongitudinalmodulationofthenasopharyngealmicrobiotaapilotstudy
AT workentinematthew asingleintranasaldoseofbacterialtherapeuticstocalvesconferslongitudinalmodulationofthenasopharyngealmicrobiotaapilotstudy
AT schwinghamertimothy asingleintranasaldoseofbacterialtherapeuticstocalvesconferslongitudinalmodulationofthenasopharyngealmicrobiotaapilotstudy
AT vandermeerfrank asingleintranasaldoseofbacterialtherapeuticstocalvesconferslongitudinalmodulationofthenasopharyngealmicrobiotaapilotstudy
AT guoyongmei asingleintranasaldoseofbacterialtherapeuticstocalvesconferslongitudinalmodulationofthenasopharyngealmicrobiotaapilotstudy
AT alexandertrevorw asingleintranasaldoseofbacterialtherapeuticstocalvesconferslongitudinalmodulationofthenasopharyngealmicrobiotaapilotstudy
AT amatsamat singleintranasaldoseofbacterialtherapeuticstocalvesconferslongitudinalmodulationofthenasopharyngealmicrobiotaapilotstudy
AT timsitedouard singleintranasaldoseofbacterialtherapeuticstocalvesconferslongitudinalmodulationofthenasopharyngealmicrobiotaapilotstudy
AT workentinematthew singleintranasaldoseofbacterialtherapeuticstocalvesconferslongitudinalmodulationofthenasopharyngealmicrobiotaapilotstudy
AT schwinghamertimothy singleintranasaldoseofbacterialtherapeuticstocalvesconferslongitudinalmodulationofthenasopharyngealmicrobiotaapilotstudy
AT vandermeerfrank singleintranasaldoseofbacterialtherapeuticstocalvesconferslongitudinalmodulationofthenasopharyngealmicrobiotaapilotstudy
AT guoyongmei singleintranasaldoseofbacterialtherapeuticstocalvesconferslongitudinalmodulationofthenasopharyngealmicrobiotaapilotstudy
AT alexandertrevorw singleintranasaldoseofbacterialtherapeuticstocalvesconferslongitudinalmodulationofthenasopharyngealmicrobiotaapilotstudy